Nike Stock Plummets: Is the Turnaround Failing?
💡 Puntos Clave
Nike's latest earnings reveal a stalled turnaround with no near-term catalyst for recovery, making the stock a risky buy despite its lower price.
What Happened: Another Disappointing Quarter
Nike's fiscal third-quarter results sent its stock tumbling, continuing a brutal year where shares are down roughly 30%. The core numbers were bleak: overall revenue was flat at $11.3 billion, and the company's gross margin shrank by 130 basis points to 40.2%, pressured by tariffs.
The geographic breakdown showed deep cracks. While North America saw a modest 3% revenue increase, key international markets struggled badly. Sales in China fell 10%, and management warned of a projected 20% plunge in Greater China for the upcoming fourth quarter. The Converse brand was a particular sore spot, with revenue collapsing by 35%.
On the earnings call, CEO Elliot Hill admitted the company's turnaround is taking longer than expected. He outlined efforts to correct past missteps, notably reducing bloated inventory in classic footwear lines that were oversaturated under the previous CEO's strategy.
There were a few glimmers of hope. The new neuroscience-based Nike Mind footwear platform was a hit, with its initial model selling out. The company is doubling production due to strong consumer interest. Additionally, Nike is rebuilding relationships with wholesale partners, moving away from an overly aggressive direct-to-consumer focus.
Why It Matters: A Long Road to Recovery
For investors, this report signals that Nike's problems are structural and won't be fixed quickly. The persistent margin decline and weak guidance, especially from the critical China market, undermine confidence in near-term profitability.
The stock's steep decline reflects a market that has lost patience. Investors are penalizing the company for a lack of clear progress and visibility into when earnings might rebound. Management itself doesn't expect gross margins to improve until the second quarter of fiscal 2027.
CEO Hill's strategy of enduring short-term pain for a long-term reset may be the right approach, but it comes with significant execution risk. Success depends on innovative products like the Mind platform gaining scale and wholesale partnerships driving sustainable growth.
Ultimately, Nike is in a multi-year transition. Without a catalyst for revenue acceleration or margin expansion in the next several quarters, the stock is likely to remain under pressure, trading on hope rather than tangible financial improvement.
Bobby Insight
Avoid Nike stock until there is concrete evidence that its turnaround plan is stabilizing sales and reversing margin erosion.
The fundamentals are deteriorating with no near-term fix in sight. While the long-term strategy has merit, the path to recovery is too long and uncertain to justify buying the dip now. The stock may not find a floor until China trends improve or margins inflect.
¿Cómo Me Afecta?
